NR 565 Advanced Pharmacology
Fundamentals | Chamberlain University
2026/2027 Study Guide, Exam Prep, Practice
Questions & Answers, Pharmacokinetics,
Pharmacodynamics, Pharmacogenomics, Drug
Classes, Therapeutics, Prescribing &
Medication Management, Adverse Effects and
Clinical Decision-Making
Question 1: A patient with a history of gastroesophageal reflux disease (GERD)
is prescribed a calcium channel blocker for hypertension. Which physiological
effect of this medication combination is most likely to exacerbate the patient's
GERD symptoms?
A. Increased lower esophageal sphincter (LES) pressure
B. Decreased gastric acid secretion
C. Decreased lower esophageal sphincter (LES) pressure
D. Increased gastric emptying time
CORRECT ANSWER: C. Decreased lower esophageal sphincter (LES) pressure
Rationale: Calcium channel blockers can cause relaxation of smooth muscle, including
the lower esophageal sphincter. A decrease in LES pressure allows for increased reflux
of gastric contents into the esophagus, thus worsening GERD symptoms.
Question 2: A patient is started on a thiazide diuretic for hypertension. Which
of the following electrolyte imbalances is the most significant concern with
long-term use of this medication class?
A. Hyperkalemia
B. Hypokalemia
C. Hypercalcemia
D. Hypermagnesemia
CORRECT ANSWER: B. Hypokalemia
Rationale: Thiazide diuretics act on the distal convoluted tubule to inhibit sodium
reabsorption, which increases sodium and water delivery to the collecting duct. This
promotes potassium secretion, leading to hypokalemia.
Question 3: In the context of managing a patient with acute decompensated
heart failure, which of the following is the primary mechanism by which loop
diuretics provide rapid symptom relief ?
A. Arterial vasodilation
B. Positive inotropic effect
C. Reduction in preload through venous pooling and diuresis
D. Inhibition of the renin-angiotensin-aldosterone system (RAAS)
,CORRECT ANSWER: C. Reduction in preload through venous pooling and
diuresis
Rationale: Loop diuretics acutely reduce preload by promoting venous dilation and rapid
diuresis. This decreases ventricular filling pressures, alleviating pulmonary congestion
and dyspnea.
Question 4: A patient on warfarin therapy is started on amiodarone for atrial
fibrillation. What is the most critical pharmacodynamic interaction that
necessitates a reduction in the warfarin dose?
A. Amiodarone displaces warfarin from protein-binding sites.
B. Amiodarone inhibits CYP2C9, leading to increased warfarin levels.
C. Amiodarone induces CYP3A4, decreasing warfarin metabolism.
D. Amiodarone has an additive antiplatelet effect.
CORRECT ANSWER: B. Amiodarone inhibits CYP2C9, leading to increased
warfarin levels.
Rationale: Amiodarone is a potent inhibitor of CYP2C9, the primary enzyme responsible
for metabolizing the more potent S-enantiomer of warfarin. This inhibition significantly
increases the INR, requiring a substantial reduction in the warfarin dose to prevent
bleeding.
Question 5: Which of the following best describes the mechanism of action of
metformin in the treatment of type 2 diabetes mellitus?
A. Stimulation of insulin secretion from pancreatic beta cells
B. Inhibition of hepatic gluconeogenesis and increased peripheral glucose uptake
C. Delayed gastric emptying and increased insulin secretion
D. Inhibition of glucose absorption in the small intestine
CORRECT ANSWER: B. Inhibition of hepatic gluconeogenesis and increased
peripheral glucose uptake
Rationale: Metformin's primary mechanism involves activating AMP-activated protein
kinase (AMPK), which reduces hepatic glucose production and enhances insulin
sensitivity in skeletal muscle, thereby improving peripheral glucose uptake without
causing significant hypoglycemia.
Question 6: A patient is prescribed a statin for hyperlipidemia. What is the
most serious adverse effect associated with this class of medications that
requires immediate medical attention?
A. Constipation
B. Myalgia
C. Rhabdomyolysis
D. Elevated liver enzymes
CORRECT ANSWER: C. Rhabdomyolysis
,Rationale: While myalgia and elevated liver enzymes are common and usually benign,
rhabdomyolysis is a rare but severe adverse effect characterized by muscle breakdown
and the release of myoglobin, which can lead to acute renal failure.
Question 7: The mechanism of action of selective serotonin reuptake inhibitors
(SSRIs) involves which of the following?
A. Blockade of serotonin (5-HT) receptors
B. Inhibition of monoamine oxidase (MAO)
C. Blockade of the reuptake of serotonin into the presynaptic neuron
D. Stimulation of serotonin release from the presynaptic neuron
CORRECT ANSWER: C. Blockade of the reuptake of serotonin into the
presynaptic neuron
Rationale: SSRIs exert their therapeutic effect by blocking the serotonin transporter
(SERT) on the presynaptic neuron. This prevents the reuptake of serotonin from the
synaptic cleft, increasing its availability to bind to postsynaptic receptors.
Question 8: A patient with a history of gout is being treated for hypertension.
Which class of antihypertensive medications is most likely to exacerbate their
gout?
A. ACE inhibitors
B. Angiotensin II receptor blockers (ARBs)
C. Thiazide diuretics
D. Beta-blockers
CORRECT ANSWER: C. Thiazide diuretics
Rationale: Thiazide diuretics reduce the excretion of uric acid in the kidneys, leading to
hyperuricemia. This can precipitate or exacerbate gout attacks in susceptible patients.
Question 9: A patient is receiving an intravenous infusion of dopamine for
cardiogenic shock. Which receptor's activation is primarily responsible for the
medication's positive inotropic effect at low to moderate doses?
A. Alpha-1 adrenergic receptors
B. Beta-1 adrenergic receptors
C. Dopamine (D1) receptors
D. Beta-2 adrenergic receptors
CORRECT ANSWER: B. Beta-1 adrenergic receptors
Rationale: At low to moderate doses, dopamine primarily stimulates beta-1 adrenergic
receptors in the heart, which increases cardiac contractility (positive inotropic effect)
and heart rate (positive chronotropic effect), thereby improving cardiac output.
Question 10: Which statement accurately describes the mechanism of action of
furosemide, a loop diuretic, at the nephron level?
, A. It inhibits the sodium-potassium-chloride cotransporter (NKCC2) in the thick
ascending limb of the loop of Henle.
B. It inhibits the sodium-chloride cotransporter (NCC) in the distal convoluted tubule.
C. It antagonizes aldosterone receptors in the collecting duct.
D. It inhibits carbonic anhydrase in the proximal convoluted tubule.
CORRECT ANSWER: A. It inhibits the sodium-potassium-chloride
cotransporter (NKCC2) in the thick ascending limb of the loop of Henle.
Rationale: Furosemide acts on the luminal membrane of the thick ascending limb of the
loop of Henle to block the NKCC2 cotransporter. This prevents the reabsorption of
sodium, potassium, and chloride, leading to a potent diuresis.
Question 11: A patient on digoxin therapy is diagnosed with hypokalemia.
What is the primary risk associated with this electrolyte imbalance in the
context of digoxin use?
A. Decreased cardiac contractility
B. Increased risk of digoxin toxicity and arrhythmias
C. Decreased serum digoxin levels
D. Increased renal clearance of digoxin
CORRECT ANSWER: B. Increased risk of digoxin toxicity and arrhythmias
Rationale: Hypokalemia enhances the binding of digoxin to the sodium-potassium
ATPase pump, increasing its toxic effects. This predisposes the patient to severe cardiac
arrhythmias, including ventricular tachycardia and heart block.
Question 12: Which of the following is a key mechanism by which
corticosteroids exert their potent anti-inflammatory effects?
A. Stimulation of phospholipase A2
B. Inhibition of phospholipase A2 and suppression of pro-inflammatory cytokines
C. Activation of nuclear factor kappa-B (NF-κB)
D. Increased production of prostaglandins and leukotrienes
CORRECT ANSWER: B. Inhibition of phospholipase A2 and suppression of pro-
inflammatory cytokines
Rationale: Corticosteroids inhibit phospholipase A2 via the induction of lipocortin-1,
which reduces the release of arachidonic acid and the subsequent production of
prostaglandins and leukotrienes. They also inhibit NF-κB, thereby suppressing the
transcription of many pro-inflammatory cytokines.
Question 13: A patient is prescribed an angiotensin-converting enzyme (ACE)
inhibitor for heart failure. Which of the following adverse effects is most
characteristic of this drug class and is related to its mechanism of action?
A. Hyperkalemia and a persistent dry cough
B. Hypokalemia and angioedema
Fundamentals | Chamberlain University
2026/2027 Study Guide, Exam Prep, Practice
Questions & Answers, Pharmacokinetics,
Pharmacodynamics, Pharmacogenomics, Drug
Classes, Therapeutics, Prescribing &
Medication Management, Adverse Effects and
Clinical Decision-Making
Question 1: A patient with a history of gastroesophageal reflux disease (GERD)
is prescribed a calcium channel blocker for hypertension. Which physiological
effect of this medication combination is most likely to exacerbate the patient's
GERD symptoms?
A. Increased lower esophageal sphincter (LES) pressure
B. Decreased gastric acid secretion
C. Decreased lower esophageal sphincter (LES) pressure
D. Increased gastric emptying time
CORRECT ANSWER: C. Decreased lower esophageal sphincter (LES) pressure
Rationale: Calcium channel blockers can cause relaxation of smooth muscle, including
the lower esophageal sphincter. A decrease in LES pressure allows for increased reflux
of gastric contents into the esophagus, thus worsening GERD symptoms.
Question 2: A patient is started on a thiazide diuretic for hypertension. Which
of the following electrolyte imbalances is the most significant concern with
long-term use of this medication class?
A. Hyperkalemia
B. Hypokalemia
C. Hypercalcemia
D. Hypermagnesemia
CORRECT ANSWER: B. Hypokalemia
Rationale: Thiazide diuretics act on the distal convoluted tubule to inhibit sodium
reabsorption, which increases sodium and water delivery to the collecting duct. This
promotes potassium secretion, leading to hypokalemia.
Question 3: In the context of managing a patient with acute decompensated
heart failure, which of the following is the primary mechanism by which loop
diuretics provide rapid symptom relief ?
A. Arterial vasodilation
B. Positive inotropic effect
C. Reduction in preload through venous pooling and diuresis
D. Inhibition of the renin-angiotensin-aldosterone system (RAAS)
,CORRECT ANSWER: C. Reduction in preload through venous pooling and
diuresis
Rationale: Loop diuretics acutely reduce preload by promoting venous dilation and rapid
diuresis. This decreases ventricular filling pressures, alleviating pulmonary congestion
and dyspnea.
Question 4: A patient on warfarin therapy is started on amiodarone for atrial
fibrillation. What is the most critical pharmacodynamic interaction that
necessitates a reduction in the warfarin dose?
A. Amiodarone displaces warfarin from protein-binding sites.
B. Amiodarone inhibits CYP2C9, leading to increased warfarin levels.
C. Amiodarone induces CYP3A4, decreasing warfarin metabolism.
D. Amiodarone has an additive antiplatelet effect.
CORRECT ANSWER: B. Amiodarone inhibits CYP2C9, leading to increased
warfarin levels.
Rationale: Amiodarone is a potent inhibitor of CYP2C9, the primary enzyme responsible
for metabolizing the more potent S-enantiomer of warfarin. This inhibition significantly
increases the INR, requiring a substantial reduction in the warfarin dose to prevent
bleeding.
Question 5: Which of the following best describes the mechanism of action of
metformin in the treatment of type 2 diabetes mellitus?
A. Stimulation of insulin secretion from pancreatic beta cells
B. Inhibition of hepatic gluconeogenesis and increased peripheral glucose uptake
C. Delayed gastric emptying and increased insulin secretion
D. Inhibition of glucose absorption in the small intestine
CORRECT ANSWER: B. Inhibition of hepatic gluconeogenesis and increased
peripheral glucose uptake
Rationale: Metformin's primary mechanism involves activating AMP-activated protein
kinase (AMPK), which reduces hepatic glucose production and enhances insulin
sensitivity in skeletal muscle, thereby improving peripheral glucose uptake without
causing significant hypoglycemia.
Question 6: A patient is prescribed a statin for hyperlipidemia. What is the
most serious adverse effect associated with this class of medications that
requires immediate medical attention?
A. Constipation
B. Myalgia
C. Rhabdomyolysis
D. Elevated liver enzymes
CORRECT ANSWER: C. Rhabdomyolysis
,Rationale: While myalgia and elevated liver enzymes are common and usually benign,
rhabdomyolysis is a rare but severe adverse effect characterized by muscle breakdown
and the release of myoglobin, which can lead to acute renal failure.
Question 7: The mechanism of action of selective serotonin reuptake inhibitors
(SSRIs) involves which of the following?
A. Blockade of serotonin (5-HT) receptors
B. Inhibition of monoamine oxidase (MAO)
C. Blockade of the reuptake of serotonin into the presynaptic neuron
D. Stimulation of serotonin release from the presynaptic neuron
CORRECT ANSWER: C. Blockade of the reuptake of serotonin into the
presynaptic neuron
Rationale: SSRIs exert their therapeutic effect by blocking the serotonin transporter
(SERT) on the presynaptic neuron. This prevents the reuptake of serotonin from the
synaptic cleft, increasing its availability to bind to postsynaptic receptors.
Question 8: A patient with a history of gout is being treated for hypertension.
Which class of antihypertensive medications is most likely to exacerbate their
gout?
A. ACE inhibitors
B. Angiotensin II receptor blockers (ARBs)
C. Thiazide diuretics
D. Beta-blockers
CORRECT ANSWER: C. Thiazide diuretics
Rationale: Thiazide diuretics reduce the excretion of uric acid in the kidneys, leading to
hyperuricemia. This can precipitate or exacerbate gout attacks in susceptible patients.
Question 9: A patient is receiving an intravenous infusion of dopamine for
cardiogenic shock. Which receptor's activation is primarily responsible for the
medication's positive inotropic effect at low to moderate doses?
A. Alpha-1 adrenergic receptors
B. Beta-1 adrenergic receptors
C. Dopamine (D1) receptors
D. Beta-2 adrenergic receptors
CORRECT ANSWER: B. Beta-1 adrenergic receptors
Rationale: At low to moderate doses, dopamine primarily stimulates beta-1 adrenergic
receptors in the heart, which increases cardiac contractility (positive inotropic effect)
and heart rate (positive chronotropic effect), thereby improving cardiac output.
Question 10: Which statement accurately describes the mechanism of action of
furosemide, a loop diuretic, at the nephron level?
, A. It inhibits the sodium-potassium-chloride cotransporter (NKCC2) in the thick
ascending limb of the loop of Henle.
B. It inhibits the sodium-chloride cotransporter (NCC) in the distal convoluted tubule.
C. It antagonizes aldosterone receptors in the collecting duct.
D. It inhibits carbonic anhydrase in the proximal convoluted tubule.
CORRECT ANSWER: A. It inhibits the sodium-potassium-chloride
cotransporter (NKCC2) in the thick ascending limb of the loop of Henle.
Rationale: Furosemide acts on the luminal membrane of the thick ascending limb of the
loop of Henle to block the NKCC2 cotransporter. This prevents the reabsorption of
sodium, potassium, and chloride, leading to a potent diuresis.
Question 11: A patient on digoxin therapy is diagnosed with hypokalemia.
What is the primary risk associated with this electrolyte imbalance in the
context of digoxin use?
A. Decreased cardiac contractility
B. Increased risk of digoxin toxicity and arrhythmias
C. Decreased serum digoxin levels
D. Increased renal clearance of digoxin
CORRECT ANSWER: B. Increased risk of digoxin toxicity and arrhythmias
Rationale: Hypokalemia enhances the binding of digoxin to the sodium-potassium
ATPase pump, increasing its toxic effects. This predisposes the patient to severe cardiac
arrhythmias, including ventricular tachycardia and heart block.
Question 12: Which of the following is a key mechanism by which
corticosteroids exert their potent anti-inflammatory effects?
A. Stimulation of phospholipase A2
B. Inhibition of phospholipase A2 and suppression of pro-inflammatory cytokines
C. Activation of nuclear factor kappa-B (NF-κB)
D. Increased production of prostaglandins and leukotrienes
CORRECT ANSWER: B. Inhibition of phospholipase A2 and suppression of pro-
inflammatory cytokines
Rationale: Corticosteroids inhibit phospholipase A2 via the induction of lipocortin-1,
which reduces the release of arachidonic acid and the subsequent production of
prostaglandins and leukotrienes. They also inhibit NF-κB, thereby suppressing the
transcription of many pro-inflammatory cytokines.
Question 13: A patient is prescribed an angiotensin-converting enzyme (ACE)
inhibitor for heart failure. Which of the following adverse effects is most
characteristic of this drug class and is related to its mechanism of action?
A. Hyperkalemia and a persistent dry cough
B. Hypokalemia and angioedema
